Protalix BioTherapeutics
PLX
#8385
Rank
โ‚น15.01 B
Marketcap
โ‚น203.94
Share price
-1.05%
Change (1 day)
61.88%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น2.53 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are โ‚น2.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น4.23 B-22.97%
2022-12-31โ‚น5.49 B-7.34%
2021-12-31โ‚น5.93 B-14.59%
2020-12-31โ‚น6.94 B-15.83%
2019-12-31โ‚น8.25 B3.51%
2018-12-31โ‚น7.97 B22.8%
2017-12-31โ‚น6.49 B3.61%
2016-12-31โ‚น6.26 B9.15%
2015-12-31โ‚น5.74 B-32.39%
2014-12-31โ‚น8.48 B-2.04%
2013-12-31โ‚น8.66 B92.83%
2012-12-31โ‚น4.49 B9.09%
2011-12-31โ‚น4.11 B20.89%
2010-12-31โ‚น3.40 B-11.28%
2009-12-31โ‚น3.84 B1136.39%
2008-12-31โ‚น0.31 B77.82%
2007-12-31โ‚น0.17 B45.89%
2006-12-31โ‚น0.11 B135.52%
2005-12-31โ‚น50.85 M1553.73%
2004-12-31โ‚น3.07 M-14.32%
2003-12-31โ‚น3.58 M-5.36%
2002-12-31โ‚น3.79 M1.7%
2001-12-31โ‚น3.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น51.39 B 1,929.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น98.18 B 3,776.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.038 T 435,655.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.922 T 115,281.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel